MENU
+Compare
NPPNY
Stock ticker: OTC
AS OF
Dec 3 closing price
Price
$15.21
Change
+$8.92 (+141.81%)
Capitalization
1.57B

NPPNY Nippon Shinyaku Co. Ltd. Forecast, Technical & Fundamental Analysis

Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company... Show more

NPPNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NPPNY with price predictions
Dec 03, 2025

NPPNY in -4.33% downward trend, sliding for three consecutive days on November 07, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NPPNY declined for three days, in of 29 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where NPPNY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

NPPNY broke above its upper Bollinger Band on December 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NPPNY entered a downward trend on November 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 17, 2025. You may want to consider a long position or call options on NPPNY as a result. In of 43 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NPPNY just turned positive on November 17, 2025. Looking at past instances where NPPNY's MACD turned positive, the stock continued to rise in of 30 cases over the following month. The odds of a continued upward trend are .

NPPNY moved above its 50-day moving average on November 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NPPNY crossed bullishly above the 50-day moving average on November 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +16 3-day Advance, the price is estimated to grow further. Considering data from situations where NPPNY advanced for three days, in of 17 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.282) is normal, around the industry mean (17.291). P/E Ratio (10.431) is within average values for comparable stocks, (72.992). NPPNY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.950). Dividend Yield (0.014) settles around the average of (0.029) among similar stocks. P/S Ratio (2.076) is also within normal values, averaging (64.427).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NPPNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPPNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
NPPNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

NPPNY paid dividends on July 15, 2024

Nippon Shinyaku Co. Ltd. NPPNY Stock Dividends
А dividend of $0.10 per share was paid with a record date of July 15, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
14, Nishinosho-Monguchi-cho
Phone
+81 753211111
Employees
1951
Web
http://www.nippon-shinyaku.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRBCX28.920.63
+2.23%
JHancock Regional Bank C
BOSCX18.220.31
+1.73%
BNY Mellon Sm Cp Val C
HLMNX30.730.19
+0.62%
Harding Loevner International Eq Inv
DESAX27.120.13
+0.48%
DWS ESG Core Equity A
PAAEX17.700.04
+0.23%
Putnam Dynamic Asset Allocation Bal R6

NPPNY and Stocks

Correlation & Price change

A.I.dvisor tells us that NPPNY and MEDIF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
+141.81%
MEDIF - NPPNY
11%
Poorly correlated
-7.66%
OVATF - NPPNY
10%
Poorly correlated
N/A
OMID - NPPNY
3%
Poorly correlated
+4.67%
OILFF - NPPNY
-1%
Poorly correlated
-8.71%
MKGAF - NPPNY
-1%
Poorly correlated
+3.49%
More

Groups containing NPPNY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
+141.81%
Pharmaceuticals: Generic
industry (213 stocks)
7%
Poorly correlated
+0.70%